Ketek will eventually be severely curtailed or go off the market

Ketek will eventually be severely curtailed or go off the market.

You'll soon see a Ketek MedGuide for patients. And there's a lot of talk of a black box warning about hepatic risk.

FDA will also reconsider Ketek's indications for sinusitis and bronchitis. These less serious infections don't justify the risk.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote